Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic resistance-the problem intensifies.

Stuart B Levy1

  • 1Center for Adaptation Genetics and Drug Resistance, Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111, USA. stuart.levy@tufts.edu

Advanced Drug Delivery Reviews
|June 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotic Use for Growth Promotion in Animals: Ecologic and Public Health Consequences.

Journal of food protection·2019
Same author

Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic <i>Escherichia coli</i>.

mBio·2018
Same author

A Novel Regulatory Cascade Involving BluR, YcgZ, and Lon Controls the Expression of <i>Escherichia coli</i> OmpF Porin.

Frontiers in microbiology·2017
Same author

Triclosan: an Instructive Tale.

Antimicrobial agents and chemotherapy·2016
Same author

Transposon-Sequencing Analysis Unveils Novel Genes Involved in the Generation of Persister Cells in Uropathogenic Escherichia coli.

Antimicrobial agents and chemotherapy·2016
Same author

Rapid radiation in bacteria leads to a division of labour.

Nature communications·2016
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Globally, antibiotic resistance is worsening with new challenges like vancomycin-resistant Staphylococcus aureus and extended-spectrum beta-lactamases. These emerging threats complicate treatment for critical infectious diseases.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Previously recognized antibiotic-resistant bacteria are increasing globally.
  • Emerging resistance mechanisms further complicate treatment of critical infectious diseases.

Purpose of the Study:

  • To highlight the growing global burden of antibiotic resistance.
  • To identify key emerging resistance challenges in common pathogens.

Main Methods:

  • Literature review and analysis of global resistance trends.
  • Identification of specific resistance mechanisms and associated pathogens.

Main Results:

  • Increasing prevalence of vancomycin resistance in Staphylococcus aureus.

Related Experiment Videos

  • Emergence of extended-spectrum beta-lactamases in gram-negative pathogens.
  • Fluoroquinolone resistance in multidrug-resistant Escherichia coli and Neisseria gonorrhoeae.

    • Conclusions:

    • New and existing antibiotic resistance mechanisms pose significant threats to public health.
    • Urgent strategies are needed to combat the rising tide of antimicrobial resistance.
    • Effective treatment of infectious diseases is increasingly challenged by resistant pathogens.